GENE ONLINE|News &
PRNewswire
Concord Medical Announces Its Subsidiary’s Application Filing for Potential Listing on The Stock Exchange of Hong Kong Limited
2022-06-01
DSM and Firmenich to merge, becoming the leading creation and innovation partner in nutrition, beauty and well-being
2022-05-31
The Global Fight Against Monkeypox: Zelixir Biotech Predicts Monkeypox Protein Structures
2022-05-30
Embracing Win-win Cooperation – ASEAN Consul Generals, officials and representatives of chambers of commerce in Guangzhou visited Biosyngen
2022-05-27
Laekna Therapeutics Announces Dosing of First Patients in the U.S. and China in Phase Ib/III Study of Afuresertib in Combination with Fulvestrant in HR+/HER2- Breast Cancer
2022-05-26
Servier Announces FDA Approval of TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine for Patients with Newly Diagnosed IDH1-mutated Acute Myeloid Leukemia
2022-05-25
Travecta Therapeutics Announces In-Person Presentation at 2022 BIO International Convention
2022-05-24
Medison Pharma Announces Extension of Multi-territorial Agreement with Immunocore and Expansion into Australia and New Zealand
2022-05-23
Clinical trial results of Belief BioMed’s hemophilia B gene therapy drug candidate BBM-H901 published in The Lancet Haematology
2022-05-19
PostEra spearheads AI-driven drug discovery collaboration to develop antiviral therapeutics with initial $68M in NIH funding
2022-05-18
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
